Domov › Ateroskleroza › North Carolina
Klinične študije za Ateroskleroza v North Carolina
12 študij za Ateroskleroza išče udeležence na lokacijah v North Carolina.
Mesta v North Carolina
Uradno besedilo študije (angleško)
A Study to Evaluate the Efficacy, Safety, Pharmacodynamics (PD), and Pharmacokinetics (PK) of Selnoflast in Reducing Vascular Inflammation in Participants With Atherosclerosis at Risk for Major Adverse Cardiac Events
- UNC Heart & Vascular, Chapel Hill
Vključevanje udeležencevFaza 2
Starost 18 in več · Vsi spoli · Posodobljeno 29. sep. 2026 · NCT07448038Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
- Care Access - Fayetteville, Fayetteville
- Medication Management, Greensboro
- Monroe Biomedical Research, Monroe
- in še 1
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 24. sep. 2026 · NCT07157774Study of the Effect of Innate on the Inflammatory Response to Endotoxin
- NIEHS Clinical Research Unit (CRU), Research Triangle Park
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
Starost 18–100 · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT01143480Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
- Novant Health Heart and Vascular Institute, Charlotte
- Velocity Clinical Research - Durham, Durham
- Moses H Cone Memorial Hospital, Greensboro
- in še 7
Vključevanje udeležencevFaza 3
Starost 45–99 · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07037433A Phase 2b Clinical Trial of YN001 in Adults With Coronary Atherosclerosis
- NC Heart and Vascular Research, LLC, Raleigh
- Javara Inc. - Wake Forest University Health Sciences, Winston-Salem
Vključevanje udeležencevFaza 2
Starost 18–80 · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07521007Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- Metrolina Nephrology Associates, PA, Charlotte
- Durham Nephrology Associates, PA, Durham
- Duke Translational Medicine Institute, Durham
- in še 3
Vključevanje udeležencevFaza 2/3
Starost 18 in več · Vsi spoli · Posodobljeno 21. sep. 2026 · NCT05485961A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
- Research Site, Asheville
- Research Site, Chapel Hill
- Research Site, Charlotte
- in še 11
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 24. avg. 2026 · NCT07000357Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD
- Wake Forest University Baptist Medical Center, Winston-Salem
Vključevanje udeležencevFaza 3
Starost 18–80 · Vsi spoli · Posodobljeno 7. avg. 2026 · NCT06813911Pelacarsen Roll-over Extension Program
- Monroe Biomedical Research, Monroe
- Alliance Medical Ministry, Raleigh
Vključevanje udeležencevFaza 3
Starost 18–100 · Vsi spoli · Posodobljeno 29. jul. 2026 · NCT06875973Pharmacogenomic Informed Statin Prescribing
- Durham VA Medical Center, Durham, NC, Durham
Vključevanje udeležencev
Starost 40–75 · Vsi spoli · Posodobljeno 13. apr. 2026 · NCT06568601Emergency Medicine Cardiovascular Risk Assessment for Lipid Disorders Trial
- Wake Forest University Health Sciences, Winston-Salem
Vključevanje udeležencevFaza 2
Starost 40–75 · Vsi spoli · Posodobljeno 27. feb. 2026 · NCT06488105Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes
- Durham VA Medical Center, Durham, NC, Durham
Vključevanje udeležencevFaza 4
Starost 18 in več · Vsi spoli · Posodobljeno 17. dec. 2025 · NCT02915198Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.